Preparing and administering COVID-19 Vaccines

Anna Bischler, Lead Medicines Information Pharmacist, Midlands and East Medicines Advice Service (East Anglia site)Published Last updated See all updates

Guidance on preparing and administering common to all available COVID-19 vaccines, and specific to individual vaccines

Purpose

Appropriate preparation and administration of COVID-19 vaccines may depend on patient characteristics and be independent of vaccine choice, or it may depend on the specific pharmaceutical characteristics of the individual vaccine.

Our guidance and standard operating procedures cover both aspects.

Additional clarifications

In addition to our SOPs, further points of clarification related to preparation and administration are as follows.

Batch numbers

Only vaccine batches approved under under Regulation 174 of the Human Medicine Regulations 2012 (as amended) are in the legitimate supply chain. Products supplied by AAH, Alloga or Movianto may be assumed to be approved. If there are any questions about a specific vaccine batch, please refer to your Regional QA Specialist.

It is not necessary for the same patient to receive both doses of vaccine from the same batch.

See further information if the same brand of vaccine is unavailable for the second dose

See also

Minimising the risk of administration of the wrong COVID-19 vaccine

1 March 2021A series of steps will help sites separate multiple vaccines as much as possible throughout the vaccination process, from receipt through to administration

Change history

  1. Information related to batch numbers added

  2. Published